| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/16/2008 | US20080254027 Optimized CD5 antibodies and methods of using the same |
| 10/16/2008 | US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders |
| 10/16/2008 | US20080254025 Using interleukin-1( IL-1) specific immunoglobulin for diagnosis, prevention and treatment of osteoarthritic, inflammatory, respiratory and autoimmune disorders |
| 10/16/2008 | US20080254024 Anti-ephb2 antibodies and methods using same |
| 10/16/2008 | US20080254023 Using erythropoietin-producing hepatocelluar kinase receptor specific interfering RNA for treatment and prevention of brain, nervous system and spinal cord disorders |
| 10/16/2008 | US20080254022 Method of Treating Airway Diseases With Beta-Adrenergic Inverse Agonists |
| 10/16/2008 | US20080254021 Tie1-binding ligands |
| 10/16/2008 | US20080254020 Protein fusions comprising immunoglobulin regions exhibiting improved bioefficacy in multidose administration for use in treatment of infection, cell proliferative, autoimmune and inflammatory disorders |
| 10/16/2008 | US20080253998 Treatment of cancer using tlr3 agonists |
| 10/16/2008 | US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
| 10/16/2008 | US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals |
| 10/16/2008 | US20080253963 Tumor markers in ovarian cancer |
| 10/16/2008 | US20080253962 Irta-4 Antibodies and Their Uses |
| 10/16/2008 | US20080253961 Drug delivery; biocompatable polyesters; biodegradable glycolic acid-lactic acid nanoshell (PLGA); controlled release |
| 10/16/2008 | CA2719055A1 Methods for decreasing immune response and treating immune conditions |
| 10/16/2008 | CA2693256A1 Methods of use of gamma inhibitor compounds for the attenuation of pain |
| 10/16/2008 | CA2683679A1 Adenoviral vector encoding malaria antigen |
| 10/16/2008 | CA2683117A1 Immunogenic compositions |
| 10/16/2008 | CA2682927A1 Anti-ige antibodies |
| 10/16/2008 | CA2682296A1 Anti-epcam antibody and uses thereof |
| 10/15/2008 | EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles |
| 10/15/2008 | EP1980616A2 E.Coli 0157: H7 C1 esterase inhibitor-binding protein STCE and uses thereof |
| 10/15/2008 | EP1980269A1 Prevention of staphylococcus biofilm formation |
| 10/15/2008 | EP1980268A2 Vaccination methods against avian influenza virus |
| 10/15/2008 | EP1980267A1 S. pneumoniae transcytosis protein |
| 10/15/2008 | EP1980266A1 New virulence factors of Streptococcus pneumoniae |
| 10/15/2008 | EP1979001A2 Binding proteins specific for insulin-like growth factors and uses thereof |
| 10/15/2008 | EP1978997A1 Transdermal delivery of pharmaceutical agents |
| 10/15/2008 | EP1978993A2 Compositions and methods for diagnosing and treating cancer |
| 10/15/2008 | EP1978985A2 Anti-hyperproliferative therapies targeting hdgf |
| 10/15/2008 | EP1978932A1 Water stabilized aerosol formulation system and method of making |
| 10/15/2008 | EP1411982B1 Modulators of p-selectin glycoprotein ligand 1 |
| 10/15/2008 | EP1387670B1 Immune modulation device for use in animals |
| 10/15/2008 | EP1372704B1 Monocyte-specific particulate delivery vehicle |
| 10/15/2008 | EP1339871B1 Diagnosis and treatment of tumor-suppressor associated disorders |
| 10/15/2008 | EP1311658B1 Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells |
| 10/15/2008 | EP1303600B1 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 10/15/2008 | EP1282703B1 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 10/15/2008 | EP1272515B1 Immunoregulator |
| 10/15/2008 | EP1247095B1 High affinity tcr proteins and methods |
| 10/15/2008 | EP1242456B1 Scfv antibodies against disease associated molecules |
| 10/15/2008 | EP1233980B1 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 10/15/2008 | EP1107785B1 Method of dna vaccination |
| 10/15/2008 | EP0915708B1 Immunogenic composition comprising tumor associated antigen and human cytokine |
| 10/15/2008 | EP0841946B2 Methods for treatment of allergic asthma |
| 10/15/2008 | CN101287988A Methods and compositions for diagnosis and treatment of influenza |
| 10/15/2008 | CN101287841A Anti-alpha(v)beta(6) antibodies and uses thereof |
| 10/15/2008 | CN101287765A 基因修饰的抗体组成物 Gene-modified antibody composition |
| 10/15/2008 | CN101287763A Chimeric antibodies with new world primate regions |
| 10/15/2008 | CN101287762A Engineered antibodies with new world primate framework regions |
| 10/15/2008 | CN101287760A Anti-IL13 human antibodies |
| 10/15/2008 | CN101287759A Methods for treating and preventing fibrosis |
| 10/15/2008 | CN101287758A Plexin D1 as a target for tumor diagnosis and therapy |
| 10/15/2008 | CN101287755A Tumor-associated peptides binding to human leukocyte antigen (HLA) class I or II molecules and related anti-cancer vaccine |
| 10/15/2008 | CN101287754A Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 10/15/2008 | CN101287752A Antigenic peptides and their use |
| 10/15/2008 | CN101287502A Compositions and methods for treating HIV infection with cupredoxin and cytochrame c |
| 10/15/2008 | CN101287493A Therapy with cd4 binding peptides and radiation |
| 10/15/2008 | CN101287492A Anti-glypican-3 antibody |
| 10/15/2008 | CN101287491A Immunogenic complex formed by vaccinal antigens encapsulated by nanostructured mesoporous silica |
| 10/15/2008 | CN101287490A Vaccination against dengue virus infection |
| 10/15/2008 | CN101287489A Production of multivalent virus like particles |
| 10/15/2008 | CN101287488A Multiple vaccination including serogroup C meningococcus |
| 10/15/2008 | CN101287485A Anti-angiogenic compounds |
| 10/15/2008 | CN101287475A Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment |
| 10/15/2008 | CN101287443A Pulse releasing system controlled by pH, preparation method and application thereof |
| 10/15/2008 | CN101285061A Fungal cell wall synthesis gene |
| 10/15/2008 | CN101285056A Hog cholera recombinant adenovirus and use thereof for preparing hog cholera genetic engineering bacterin |
| 10/15/2008 | CN101284874A Peptide-based immunization therapy for treatment of atherosclerosis |
| 10/15/2008 | CN101284130A Method for using a reverse genetic engineering platform to produce protein vaccinces and protein vaccine of avian influenza virus |
| 10/15/2008 | CN100425692C Method for preparing rabbitpox culturing tissue containing high-quality physiological activity |
| 10/15/2008 | CN100425291C O-type foot-and-mouth disease virus poly-gene duplication defect type adenovirus active carrier vaccine and process for preparing the same |
| 10/15/2008 | CN100425290C CCA gene vaccine, and its establishing method and use for preparing vaccine for preventing and treating tumour |
| 10/15/2008 | CN100425288C Nasal cavity spraying inactivated influenza virus vaccine and its prepn process |
| 10/15/2008 | CN100425287C Tumor vaccines |
| 10/14/2008 | US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences |
| 10/14/2008 | US7435803 Genetic engineered, chimera and human monoclonal antibodies that bind to lymphocytes CD antigens, used for diagnosis and prohylaxis of cancer and autoimmune diseases |
| 10/14/2008 | US7435802 Bind to alpha-4 integrin; asthma, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, transplant rejection, graft versus host disease, tumor metastasis, nephritis, atopic dermatitis, psoriasis, myocardial ischemia, acute leukocyte mediated lung injury |
| 10/14/2008 | US7435799 TNF-α binding molecules |
| 10/14/2008 | US7435797 Anti-HER2 antibody variants |
| 10/14/2008 | US7435796 Beta-like glycoprotein hormone polypeptide specific immunoglobulin for treatment of autoimmune, inflammatory, (such as rheumatoid arthritis, psoriasis, multiple sclerosis, toxic shock, bone marrow and organ transplantation disorders |
| 10/14/2008 | US7435792 Hybrid proteins that migrate retrogradely and transynaptically into the CNS |
| 10/14/2008 | US7435790 Dihydroxypropyl cysteine peptide and agent containing this peptide |
| 10/14/2008 | US7435734 Such as N-(2-ethoxybenzyl)-5-hydroxy-1-methyl-2-(4-methylphenyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide; inhibitors of HIV replication; with other HIV/AIDS antivirals, anti-infectives, immunomodulators, antibiotics or vaccines; AIDS |
| 10/14/2008 | US7435721 Of pestviruses as drug delivery devices for type-specific diagnosis of infection, for eliciting antibiotic activity, and for transport of substances into a cell |
| 10/14/2008 | US7435590 Recognizes human epiregulin (hEPR); detection of human tumors which express hEPR |
| 10/14/2008 | US7435585 Auto-stimulating cells and methods for making and using the same |
| 10/14/2008 | US7435554 Immunoglobulin specific to lung cancer cell surface protein for use as tool in detection and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics; antitumor agents |
| 10/14/2008 | US7435551 Monoclonal antibody which does not bind with a monomeric adiponectin (GBP28) but specifically binds with GBP28 having a trimer structure or aggregated GBP28 trimers by recognizing an epitope on the structure; especially for diagnosing type II diabetes at an early stage; measuring a level of adiponectin |
| 10/14/2008 | US7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope |
| 10/14/2008 | US7435422 protein free; an alcohol (or polyhydroxyalcohol such as dextran), a sugar (mono/polysaccharide), and a buffer; lyophilization; further comprising a soybean peptone |
| 10/14/2008 | US7435421 Derivatives of choline binding proteins for vaccines |
| 10/14/2008 | US7435420 Dipeptidyl peptidase IV inhibitors for the treatment of anxiety |
| 10/14/2008 | US7435419 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 10/14/2008 | US7435418 Isolated polypeptide comprising a claimed amino acid sequence |
| 10/14/2008 | US7435417 Pharmaceutical composition containing disrupted cell suspension of Monilia albicans and euglobulin and method of treating animals infected with canine distemper virus or animals having neurological disorders by using the same |
| 10/14/2008 | US7435416 Anti-tumor antibody compositions and methods of use |
| 10/14/2008 | US7435415 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 10/14/2008 | US7435414 Humanized antibody against S-surface antigen of hepatitis B virus |
| 10/14/2008 | US7435413 Using blood coagulation factor to identify antibodies which modulate, prevent and treat tumors, inflammation, septic shock, hypotension and adult respiratory distress syndrome |